Empagliflozin alleviates renal inflammation in Sprague Dawley diabetic rats by inhibiting TLR4 / NF-κB pathway and NLRP3 inflammasome activation

Author:

Wei Jianbin1,Zeng Xiaochun1,Ji Kuirong1,Zhang Lingyi1,Fan Mingliang1,Hao Lanxiang2,Chen Xiaomin1

Affiliation:

1. Department of Endocrinology and Metabolism, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University

2. Department of Pathology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University

Abstract

Abstract

Aims To investigate the potential effects of the SGLT2 inhibitor empagliflozin on renal inflammatory pathways in diabetic rats. Materials and Methods Sprague Dawley (SD) diabetic rats model was established by intraperitoneal injection of streptozotocin (STZ, 35 mg/kg) after 4-week high-sugar and high-fat diet intervention. Rats were randomly assigned to three groups: normal control (NC), diabetes with normal saline (DM + NS), and diabetes with empagliflozin (DM + EMP). Empagliflozin (10mg/kg/day) or equivalent volume of normal saline was administered to the appropriate group. After 4 weeks intervention, the rats were euthanized, and kidney tissues were obtained. The mRNA transcription levels of TLR4, NF-κB, NLRP3, IL-1β, IL-18, caspase-1, caspase-3, and TGF-β1 were assessed using the RT-qPCR. Additionally, Western blot analysis was conducted to determine TLR4, NF-κB, NLRP3 and IL-18 protein expression levels in the rat kidneys. Results Compared to the DM + NS group, the mRNA levels of TLR4, NF-κB, NLRP3, and IL-18 were significantly decreased in the DM + EMP group, TLR4[1.02 (0.32, 2.66) vs. 0.17(0.06, 0.27), P = 0.022], NF-κB[1.38 (1.12, 2.05) vs. 0.82(0.69, 1.00), P = 0.002], and NLRP3[0.60 (0.13, 0.93) vs. 0.04(0.03, 0.18), P = 0.025], IL-18[1.66(1.50, 1.76) vs. 6.68(2.17, 11.16), P = 0.002], respectively. The mRNA levels of IL-1β, caspase-1, caspase-3, and TGF-β1 were demonstrated a significant decrease, but did not reach statistical significance. Empagliflozin attenuated the protein expression of TLR4, NF-κB, NLRP3 and IL-18, which seem to restore to near normal control levels. Conclusion Our research suggests that empagliflozin may exert anti-inflammatory effects in the kidney tissue by inhibiting the TLR4/NF-κB axis activation and the priming of NLRP3 inflammasome.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3